Mutaflor (Escherichia Coli Strain Nissle 1917)

Escherichia coli Nissle 1917, the active ingredient in Mutaflor, is a probiotic presented as a 10^9 CFU per capsule for oral use. It is employed to support maintenance of remission in ulcerative colitis and to aid gastrointestinal health in other conditions. GNH USA supplies Mutaflor as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mutaflor is a probiotic that acts on the gastrointestinal microbiota to improve disease outcomes. - Ulcerative colitis: helps maintain remission and reduce flare‑ups. - Irritable bowel syndrome: may alleviate abdominal discomfort and irregular bowel habits. - Antibiotic‑associated diarrhea: assists in preventing diarrhea that can follow broad‑spectrum antibiotic therapy.

Mutaflor is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Bloating: mild abdominal distension reported by some users. - Flatulence: increased intestinal gas may be experienced. - Nausea: occasional feeling of queasiness. - Diarrhea: transient loose stools in the initial treatment period.

Serious or Rare Side Effects: - Sepsis: rare bloodstream infection, primarily in severely immunocompromised patients. - Bacteremia: presence of the probiotic strain in blood, reported in vulnerable individuals. - Severe allergic reaction: anaphylaxis or angioedema in hypersensitive patients. - Infection of central lines: possible colonisation of indwelling devices in high‑risk settings.

Before prescribing Mutaflor, clinicians should consider patient‑specific factors and follow safe handling practices. - Immune status assessment: evaluate for severe immunosuppression before use. - Caution in critical illness: avoid in patients with uncontrolled sepsis or organ failure. - Monitor for infection signs: watch for fever, chills, or gastrointestinal bleeding. - Concomitant antibiotics: be aware that broad‑spectrum antibiotics may diminish probiotic efficacy. - Store at room temperature: keep in the original pack, protect from moisture.

Mutaflor may interact with other agents that alter gut flora or immune function.

Major Interactions (Avoid): - Broad‑spectrum antibiotics: can eradicate the probiotic strain, reducing benefit. - Immunosuppressants: may increase risk of opportunistic infection. - Antifungal agents (e.g., fluconazole): potential alteration of microbial balance.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: altered gastric pH may affect bacterial survival. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase gastrointestinal irritation. - Live vaccines: probiotic may modulate immune response to vaccination.